Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Stoke Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −9 vs. Q1 2021
- Shares held
- 20.2M
- −18.2M (−47.4%) vs. Q1 2021
- Total value
- $680.3M
- −$812.0M (−54.4%) vs. Q1 2021
- New holders
- 11
- 41 more added
- Sold out
- 20
- 26 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $2.49B |
| Q1 2026 | 198 | $2.31B |
| Q4 2025 | 183 | $2.13B |
| Q3 2025 | 151 | $1.57B |
| Q2 2025 | 134 | $744.0M |
| Q1 2025 | 126 | $421.6M |
| Q4 2024 | 130 | $640.4M |
| Q3 2024 | 118 | $715.5M |
| Q2 2024 | 115 | $828.5M |
| Q1 2024 | 103 | $731.7M |
| Q4 2023 | 81 | $236.9M |
| Q3 2023 | 97 | $173.1M |
| Q2 2023 | 100 | $494.8M |
| Q1 2023 | 97 | $371.8M |
| Q4 2022 | 107 | $371.8M |
| Q3 2022 | 105 | $544.4M |
| Q2 2022 | 92 | $569.4M |
| Q1 2022 | 99 | $870.6M |
| Q4 2021 | 94 | $849.6M |
| Q3 2021 | 90 | $492.4M |
| Q2 2021 | 97 | $680.3M |
| Q1 2021 | 106 | $1.49B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aviva PLC | 0 | $0 | 0.00% | −30,266−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −13,692−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,708−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,718−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −7,682−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6,151−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −811−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −515−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Anchor Investment Management, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Close Asset Management Ltd | 0 | $0 | 0.00% | −4−100.0% | Sold out |